According to a new market research study titled ‘Cardiovascular Devices Market to 2027 – Global Analysis and Forecasts by Device, Application, End User and Geography. The global cardiovascular devices market is expected to reach US$ 71.1 Bn in 2027 from US$ 40.8 Bn in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027. The market is likely to grow due to the wide utilization of the device so as to monitor the cardiac events for the patients with different cardiac conditions.
Cardiovascular devices are the medical devices designed for monitoring, preventing, diagnosing, and treating diseases associated to cardiovascular system or heart related diseases. The various cardiovascular devices available in the market include electrocardiography (ECG), pacemaker, stent, defibrillator, cardiac catheter, guidewire, heart valve, event monitor, and many more. These devices aid in regular heart functioning in patients with heart abnormalities.
Global cardiovascular devices market, based on device was segmented as, electrocardiography (ECG), pacemaker, stent, defibrillator, cardiac catheter, guidewire, heart valve, event monitor and other devices. In 2018, the event monitor segment held the largest share of the market, by device. However, the ECG segment is expected to witness fastest growth at a fastest growth rate during 2019 to 2027.
The major players operating in the cardiovascular devices market, Medtronic, Boston Scientific Corporation, Abbott, Biosense Webster, Inc (Johnson and Johnson), General Electric Company, Koninklijke Philips N.V, Siemens AG, BD, B. Braun Melsungen AG and Edwards Lifesciences Corporation among the others.
The report segments the global cardiovascular devices market as follows:
Global Cardiovascular Devices Market – By Device
Global Cardiovascular Devices Market – By Application
Global Cardiovascular Devices Market – By End User
Global Cardiovascular Devices Market – By Geography
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@reportsweb.com